MICHAEL W BONNEY Insider Trading $SRPT Sarepta Therapeutics, Inc.
Get free email notifications about insider trading for MICHAEL W BONNEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W BONNEY. MICHAEL W BONNEY is Director in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and Director in CELGENE CORP /DE/ ($CELG) and Director in NPS PHARMACEUTICALS INC ($NPSP) and Chief Executive Officer in CUBIST PHARMACEUTICALS INC ($CBST) and President & CEO in CUBIST PHARMACEUTICALS INC ($CBST) and President and CEO in CUBIST PHARMACEUTICALS INC ($CBST) and Director in Sarepta Therapeutics, Inc. ($SRPT) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Global Blood Therapeutics, Inc. ($GBT) and Director in Tekla World Healthcare Fund ($THW) and Director in Magenta Therapeutics, Inc. ($MGTA) and Director in Kaleido Biosciences, Inc. ($KLDO) and Executive Chair in Kaleido Biosciences, Inc. ($KLDO).
MICHAEL W BONNEY in Sarepta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Director
Holdings: 9,126 shares
Current Value: $266,205
Latest Transaction: Feb 28 2020
$SRPT Market Capitalization: $1.60B
$SRPT Previous Close: $29.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL W BONNEY in Sarepta Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BMY, CELG, CBST, GBT, KLDO, MGTA, NPSP, SRPT, SYRS, THW
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 2,075 | 0 | 9,126 | 7.1 K to 9.1 K (+29.43 %) |
| Sep 09 2019 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Buy | P | 86.74 | 2,000 | 173,480 | 7,051 | 5.1 K to 7.1 K (+39.60 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 1,633 | 0 | 5,051 | 3.4 K to 5.1 K (+47.78 %) |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 3,418 | 0 | 3,418 | 0 to 3.4 K |
| Dec 05 2017 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 54.29 | 16,400 | 890,356 | 16,400 |
Page: 1